|8-KFeb 26, 8:00 AM ET

Roadzen Inc. 8-K

Research Summary

AI-generated summary

Updated

Roadzen Inc. Amends Convertible Notes; Investor Financing Participation

What Happened
Roadzen Inc. announced on February 25, 2026 that it entered into a Second Amendment to its Securities Purchase Agreement (SPA) and the junior convertible notes issued under that SPA. The amendment revises the first and second installment dates under the November 2025 notes to April 21, 2026 and May 21, 2026, respectively, and amends the SPA to give the institutional investor a right to participate in certain financings the company may complete before June 20, 2026. The SPA was originally entered into on November 20, 2025 and the notes were previously amended on January 20, 2026.

Key Details

  • Amendment date: February 25, 2026.
  • Revised installment dates for the November 2025 junior convertible notes: April 21, 2026 and May 21, 2026.
  • Investor granted a participation right in certain financings occurring prior to June 20, 2026, subject to conditions and limitations in the amendment.
  • The full Second Amendment is filed as Exhibit 10.1 to the Form 8‑K.

Why It Matters
This filing changes the timing of the company’s convertible note installments and gives the investor an opportunity to take part in near‑term financings, which could affect future dilution and the company’s access to capital. For investors, the modification is material because it alters near-term cash-flow/timing expectations tied to the notes and could influence how upcoming funding rounds are allocated. The 8‑K does not disclose new financial results or dollar amounts for the financings—review the filed Exhibit 10.1 for full terms.